GF Fund Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
GF Fund Management's ARQT Position: Q3 2026 in Review
GF Fund Management increased its Arcutis Biotherapeutics (ARQT) stake by 34% in Q3 2026, buying an estimated $23.6K and bringing the position to 3,529 shares worth $93.3K. The position accounts for ﹤0.01% of the portfolio, ranked #340.
GF Fund Management first reported a position in ARQT in Q4 2024 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- GF Fund Management held 3,529 shares of Arcutis Biotherapeutics worth $93.3K as of Q3 2026.
- GF Fund Management bought 903 Arcutis Biotherapeutics shares in Q3 2026, an estimated $23.6K.
- Arcutis Biotherapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #340 holding.
- GF Fund Management first reported a position in Arcutis Biotherapeutics in Q4 2024 and has held it in 8 quarters since.
- 212 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.